Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386 · see citing works

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works

Standards of Medical Care in Diabetes

Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,672 · see citing works

Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

El-Sadr, W. M., & The Data Collection On Adverse Events Of Anti-HIV Drugs (DAD) Study Group (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,677 · see citing works

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

Friis‐Møller, N., Weber, R. K., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M. G., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,076 · see citing works

Standards of Medical Care in Diabetes

(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 684 · see citing works

Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection

Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 626 · see citing works

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

Mary‐Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. G. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 563 · see citing works

Coronary Heart Disease in HIV-Infected Individuals

Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J., & Hodder, S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00012 · Cited by 537 · see citing works

Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study

Brindle, P. M., Emberson, J., Lampe, F. C., Walker, M., Whincup, P. H., Fahey, T. P., & Ebrahim, S. B. J. (2003) · BMJ · doi:10.1136/bmj.327.7426.1267 · Cited by 524 · see citing works

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., & Janssen, R. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11672-2 · Cited by 487 · see citing works

Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV-1 Infection?

Klein, D., Hurley, L. B., Quesenberry, C. P., & Sidney, S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200208150-00002 · Cited by 418 · see citing works

Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

Fontas, É., van Leth, F., Sabin, C. A., Friis‐Møller, N., Rickenbach, M., Monforte, A. D., Kirk, O., Dupon, M., Morfeldt, L., Mateu, S., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381783 · Cited by 337 · see citing works

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

Fellay, J., Ledergerber, B., Bernasconi, E., Furrer, H., Battegay, M., Hirschel, B. J., Vernazza, P., Francioli, P. B., Greub, G., Flepp, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06413-3 · Cited by 329 · see citing works

Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

Law, M. G., Friis‐Møller, N., Weber, R. K., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Calvo, G., et al. (2003) · HIV Medicine · doi:10.1046/j.1468-1293.2003.00138.x · Cited by 248 · see citing works

Lipid Profiles for Antiretroviral-Naive Patients Starting Pi- and Nnrti-Based Therapy in the Swiss HIV Cohort Study

Study, T. S. H. C., Young, J., Weber, R. K., Rickenbach, M., Furrer, H., Bernasconi, E., Hirschel, B. J., TARR, P. E., Vernazza, P., Battegay, M., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000511 · Cited by 128 · see citing works

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

Bergersen, B. M., Sandvik, L., Bruun, J. N., & Tonstad, S. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1177-6 · Cited by 126 · see citing works

Evaluation and management of dyslipidemia in patients with HIV infection

Green, M. L. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.20201.x · Cited by 68 · see citing works

Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study)

Santos, J. C. D. C., Palacios, R., González, M., Ruiz, J., & Márquez, M. (2005) · International Journal of STD & AIDS · doi:10.1258/095646205774357398 · Cited by 44 · see citing works

Empfehlungen 1999 zur Behandlungsindikation des Risikofaktors Cholesterin

Battegay, E., Bertel, O., & Gutzwiller, F. (2000) · Zurich Open Repository and Archive (University of Zurich) · Cited by 7 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias

Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706 · see citing works

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

Worm, S. W., Sabin, C. A., Weber, R. K., Reiss, P., El-Sadr, W. M., Dabis, F., Wit, S. D., Law, M. G., Monforte, A. D., Friis‐Møller, N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 644 · see citing works

HIV infection and cardiovascular disease

Hemkens, L. G., & Bucher, H. C. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht528 · Cited by 251 · see citing works

Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010

Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M., & Skarbinski, J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000304 · Cited by 213 · see citing works

Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women

Kaplan, R. C., Kingsley, L., Sharrett, A. R., Li, X., Lazar, J., Tien, P. C., Mack, W. J., Cohen, M. H., Jacobson, L. P., & Gange, S. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521935 · Cited by 219 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192 · see citing works

Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension

Grossman, E., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.024 · Cited by 183 · see citing works

Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapy Era

Bedimo, R., Westfall, A. O., Drechsler, H., Vidiella, G., & Tebas, P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir269 · Cited by 147 · see citing works

Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy

Bækken, M., Os, I., Sandvik, L., & Oektedalen, O. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830ef5fb · Cited by 125 · see citing works

Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy

Hsu, D. C., Ma, Y. F., Hur, S., Li, D., Rupert, A. W., Scherzer, R., Kalapus, S. C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2016) · AIDS · doi:10.1097/qad.0000000000001149 · Cited by 99 · see citing works

Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus

Worm, S. W., Wit, S. D., Weber, R. K., Sabin, C. A., Reiss, P., El-Sadr, W. M., Monforte, A. D., Kirk, O., Fontas, É., Dabis, F., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.790857 · Cited by 96 · see citing works

Drug induced hypertension – An unappreciated cause of secondary hypertension

Grossman, A., Messerli, F. H., & Grossman, E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.027 · Cited by 95 · see citing works

Self-Management Education Programs for People Living with HIV/AIDS: A Systematic Review

Millard, T. N., Elliott, J., & Girdler, S. J. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0294 · Cited by 91 · see citing works

Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure

van Zoest, R. A., Wit, F. W. N. M., Kooij, K. W., van der Valk, M., Schouten, J., Kootstra, N. A., Wiersinga, W. J., Prins, M., van den Born, B. H., & Reiss, P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw285 · Cited by 89 · see citing works

The Burden of Diabetes and Hyperlipidemia in Treated HIV Infection and Approaches for Cardiometabolic Care

Samaras, K. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0124-x · Cited by 88 · see citing works

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

Reinsch, N., Neuhaus, K., Eßer, S., Potthoff, A. V., Hower, M., Mostardt, S., Neumann, A., Brockmeyer, N. H., Gelbrich, G., Erbel, R., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711398431 · Cited by 85 · see citing works

Hypertension in people living with HIV

van Zoest, R. A., van den Born, B. H., & Reiss, P. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000406 · Cited by 77 · see citing works

Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study

Petoumenos, K., Worm, S. W., Fontas, É., Weber, R. K., Wit, S. D., Bruyand, M., Reiss, P., El-Sadr, W. M., Monforte, A. D., Friis‐Møller, N., et al. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17426 · Cited by 70 · see citing works

Guía de la ESC/EAS sobre el manejo de las dislipemias

Reiner, Ž., Catapano, A. L., Backer, G. D., Graham, I. M., Taskinen, M., Wiklund, O., Agewall, S., Alegría, E., Chapman, M. J., Durrington, P. N., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.09.014 · Cited by 64 · see citing works

Cardiovascular implications of HIV-induced dyslipidemia

Giannarelli, C., Klein, R. S., & Badimón, J. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.003 · Cited by 65 · see citing works

Cardiovascular disease in patients with HIV

Ballocca, F., D’Ascenzo, F., Gili, S., Marra, W. G., & Gaïta, F. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.06.005 · Cited by 64 · see citing works

HIV and its relationship to insulin resistance and lipid abnormalities

Non, L. R., Escota, G. V., & Powderly, W. G. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.007 · Cited by 60 · see citing works

Cardiovascular Risk-Factor Knowledge and Risk Perception Among HIV-Infected Adults

Cioe, P. A., Crawford, S. L., & Stein, M. D. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2013.07.006 · Cited by 60 · see citing works

Comorbidity-Related Treatment Outcomes among HIV-Infected Adults in the Bronx, NY

Chu, C., Umanski, G., Blank, A. E., Meißner, P., Grossberg, R. M., & Selwyn, P. A. (2011) · Journal of Urban Health · doi:10.1007/s11524-010-9540-7 · Cited by 59 · see citing works

Risk of Cardiovascular Events and Blood Pressure Control in Hypertensive HIV-Infected Patients

Nüesch, R., Wáng, Q., Elzi, L., Bernasconi, E., Weber, R. K., Cavassini, M. L., Vernazza, P., Thurnheer, M. C., Calmy, A., Battegay, M., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182847cd0 · Cited by 58 · see citing works

Perfil lipídico, fatores de risco cardiovascular e síndrome metabólica em um grupo de pacientes com AIDS

da Silva, É. F. R., Bassichetto, K. C., & Lewi, D. S. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009000800008 · Cited by 56 · see citing works

HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era

Ballocca, F., Gili, S., D’Ascenzo, F., Marra, W. G., Cannillo, M., Calcagno, A., Bonora, S., Flammer, A. J., Coppola, J., Moretti, C., et al. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.02.008 · Cited by 56 · see citing works

The Relationship Between HIV Infection and Cardiovascular Disease

Dau, B., & Holodniy, M. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160589 · Cited by 56 · see citing works

Tobacco Smoking in HIV-Infected versus General Population in France: Heterogeneity across the Various Groups of People Living with HIV

Tron, L., Lert, F., Spire, B., Dray‐Spira, R., & the ANRS-Vespa2 study group (2014) · PLoS ONE · doi:10.1371/journal.pone.0107451 · Cited by 53 · see citing works

Metabolic Syndrome in Older HIV-Infected Patients: Data from the CORE50 Cohort

Adeyemi, O. M., Rezai, K., Bahk, M., Badri, S. M., & Thomas-Gossain, N. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0119 · Cited by 54 · see citing works

Increased risk of cardiovascular disease ( CVD ) with age in HIV ‐positive men: a comparison of the D : A : D CVD risk equation and general population CVD risk equations

Petoumenos, K., Reiss, P., Ryom, L., Rickenbach, M., Sabin, C. A., El-Sadr, W. M., Monforte, A. D., Phillips, A. N., Wit, S. D., Kirk, O., et al. (2014) · HIV Medicine · doi:10.1111/hiv.12162 · Cited by 52 · see citing works

High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC

Levy, M., Ae, G., Hart, R. A., Happ, L. P., Hadigan, C. M., & Castel, A. D. (2017) · HIV Medicine · doi:10.1111/hiv.12516 · Cited by 53 · see citing works

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus

Moreno, J. A., Beltrán, L. M., Rubio‐Navarro, A., Puig, J. G., Amaro-Villalobos, J. M., & Egido, J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s65885 · Cited by 51 · see citing works

Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis

Weinberger, A. H., Smith, P. H., Funk, A. P., Rabin, S., & Shuter, J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001279 · Cited by 51 · see citing works

Secondary Hypertension: Interfering Substances

Grossman, E., & Messerli, F. H. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07758.x · Cited by 49 · see citing works

Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years—The Australian Positive & Peers Longevity Evaluation Study (APPLES)

Petoumenos, K., Huang, R., Hoy, J., Bloch, M. T., Templeton, D. J., Baker, D. A., Giles, M., Law, M. G., & Cooper, D. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184583 · Cited by 49 · see citing works

Burden, Determinants, and Pharmacological Management of Hypertension in HIV-Positive Patients and Populations: A Systematic Narrative Review.

Nguyen, K. A., Peer, N., Mills, E. J., & Kengne, A. P. (2015) · PubMed · Cited by 47 · see citing works

Microbial Translocation and Cardiometabolic Risk Factors in HIV Infection

Trøseid, M., Manner, I. W., Pedersen, K. K., Haissman, J. M., Kvale, D., & Nielsen, S. D. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0280 · Cited by 41 · see citing works

Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients

Calza, L., Colangeli, V., Manfredi, R., Bon, I., Re, M. C., & Viale, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv494 · Cited by 42 · see citing works

Preparedness of HIV care and treatment clinics for the management of concomitant non–communicable diseases: a cross–sectional survey

Leung, C. L., Aris, E. A., Mhalu, A., Siril, H. N., Christian, B., Koda, H., Samatta, T., Tsere, M., Hirschhorn, L. R., Chalamilla, G., et al. (2016) · BMC Public Health · doi:10.1186/s12889-016-3661-1 · Cited by 42 · see citing works

Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries

Lang, S., Boccara, F., Mary‐Krause, M., & Cohen, A. A. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.01.004 · Cited by 41 · see citing works

Management of metabolic complications and cardiovascular risk in HIV-infected patients.

Blanco, F., Román, J. S., Vispo, E., López, M., Salto, A., Abad, V., & Soriano, V. (2010) · PubMed · Cited by 40 · see citing works

Estado nutricional, clínico e padrão alimentar de pessoas vivendo com HIV/Aids em assistência ambulatorial no município de São Paulo

Silva, E. F. R., Lewi, D. S., Vedovato, G. M., Garcia, V. R. S., Tenore, S. B., & Bassichetto, K. C. (2010) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2010000400012 · Cited by 39 · see citing works

Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde - Cameroon: a randomized trial study

Ngo-Matip, M.-E., Pieme, C. A., Azabji‐Kenfack, M., Nya, P. C. B., Germaine, N., Heike, E., Moukette, B. M., Emmanuel, K., Philippe, S., Mbofung, C. M., et al. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-191 · Cited by 39 · see citing works

The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia

Heron, J. E., Norman, S. M., Yoo, J., Lembke, K., O'Connor, C. C., Weston, C. E., & Gracey, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223224 · Cited by 38 · see citing works

Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era — Role of chronic renal disease

Hentzien, M., Dramé, M., Allavena, C., Jacomet, C., Valantin, M., Cabie, A., Cuzin, L., Rey, D., Puglièse, P., & Bani‐Sadr, F. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0608-7 · Cited by 37 · see citing works

Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV

Kramer, A. S., Lazzarotto, A. R., Sprinz, E., & Manfrói, W. C. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009001100019 · Cited by 36 · see citing works

Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals

Worm, S. W., Sabin, C. A., Reiss, P., El-Sadr, W. M., Monforte, A. D., Pradier, C., Thiébaut, R., Law, M. G., Rickenbach, M., Wit, S. D., et al. (2008) · Diabetes Care · doi:10.2337/dc08-1394 · Cited by 36 · see citing works

Observational Research on NCDs in HIV-Positive Populations

Petersen, M. L., Yiannoutsos, C. T., Justice, A. C., & Egger, M. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000253 · Cited by 35 · see citing works

Prevalence of traditional cardiovascular risk factors and evaluation of cardiovascular risk using three risk equations in Nigerians living with human immunodeficiency virus

Edward, A., Oladayo, A., Adetiloye, A. A., Adedayo, P., & Omolola, A. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.123251 · Cited by 34 · see citing works

Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV

Cioe, P. A., Gordon, R. E. F., Guthrie, K. M., Freiberg, M. S., & Kahler, C. W. (2018) · AIDS Care · doi:10.1080/09540121.2018.1489103 · Cited by 34 · see citing works

Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort

Domingo, P., Suárez-Lozano, I., Teira, R., Fernando, L., Terrón, A., Pompeyo, V., Juan, G., José, G. M., Geijo, P., Vergara, A., et al. (2008) · The Open AIDS Journal · doi:10.2174/1874613600802010026 · Cited by 34 · see citing works

HIV-infected patients and treatment outcomes: an equivalence study of community-located, primary care-based HIV treatment vs. hospital-based specialty care in the Bronx, New York

Chu, C., Umanski, G., Blank, A. E., Grossberg, R. M., & Selwyn, P. A. (2010) · AIDS Care · doi:10.1080/09540121.2010.484456 · Cited by 33 · see citing works

The metabolic syndrome in HIV

Worm, S. W., & Lundgren, J. D. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.018 · Cited by 33 · see citing works

Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study

Manner, I. W., Bækken, M., Oektedalen, O., & Os, I. (2012) · Blood Pressure · doi:10.3109/08037051.2012.680742 · Cited by 33 · see citing works

Can the Risk of Cardiovascular Disease in HIV-Infected Patients Be Estimated from Conventional Risk Prediction Tools?

Friis‐Møller, N., & Worm, S. W. (2007) · Clinical Infectious Diseases · doi:10.1086/521936 · Cited by 33 · see citing works

Should HIV therapy be started at a CD4 cell count above 350 cells/μl in asymptomatic HIV-1-infected patients?

Sabin, C. A., & Phillips, A. N. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328326cd34 · Cited by 30 · see citing works

The Prevalence and Associated Factors of Hypertension among HIV Patients

Mbuthia, G. W., Magutah, K., & McGarvey, S. T. (2021) · International Journal of Hypertension · doi:10.1155/2021/5544916 · Cited by 30 · see citing works

Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities

Cope, R. J., Berkowitz, L. B., Arcebido, R., Yeh, J., Trustman, N., & Cha, A. (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0018 · Cited by 30 · see citing works

Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV

Cioe, P. A., Baker, J. V., Kojic, E. M., Önen, N. F., Hammer, J., Patel, P., & Kahler, C. W. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000759 · Cited by 29 · see citing works

HIV infection, aging and cardiovascular disease: epidemiology and prevention

Petoumenos, K., & Worm, S. W. (2011) · Sexual Health · doi:10.1071/sh11020 · Cited by 27 · see citing works

A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era

D'Ascenzo, F., Quadri, G., Cerrato, E., Calcagno, A., Omedè, P., Marra, W. G., Abbate, A., Bonora, S., Zoccai, G. B., Moretti, C., et al. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328365ca31 · Cited by 27 · see citing works

Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy

Young, J., Glass, T. R., Bernasconi, E., Rickenbach, M., Furrer, H., Hirschel, B. J., TARR, P. E., Vernazza, P., Battegay, M., & Bucher, H. C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.07.015 · Cited by 26 · see citing works

Smoking Cessation Interventions in HIV-Infected Adults in North America: A Literature Review

Cioe, P. A. (2013) · Journal of Addictive Behaviors Therapy & Rehabilitation · doi:10.4172/2324-9005.1000112 · Cited by 25 · see citing works

Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms

Policarpo, S., Rodrigues, T., Moreira, A. C., & Valadas, E. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.08.002 · Cited by 25 · see citing works

Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression

D’Antoni, M. L., Mitchell, B. I., McCurdy, S., Byron, M. M., Ogata-Arakaki, D., Chow, D. C., Mehta, N. N., Boisvert, W. A., Lefebvre, E. A., Shikuma, C. M., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5a0817-328rrr · Cited by 24 · see citing works

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe

Zhou, D. T., Kodogo, V., Chokuona, K. F. V., Øktedalen, O., Stray‐Pedersen, B., & Gomo, E. (2015) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s78523 · Cited by 23 · see citing works

Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy

Begovać, J., Dragović, G., Višković, K., Kušić, J., Mihanović, M. P., Lukas, D., & Jevtović, D. (2015) · Croatian Medical Journal · doi:10.3325/cmj.2015.56.14 · Cited by 23 · see citing works

Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy

Chow, D. C., Stein, J. H., Seto, T. B., Mitchell, C., Sriratanaviriyakul, N., Grandinetti, A., Gerschenson, M., Shiramizu, B. T., Souza, S. A., & Shikuma, C. M. (2010) · AIDS · doi:10.1097/qad.0b013e3283383016 · Cited by 22 · see citing works

Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance

Freitas, P., Carvalho, D. M., Santos, A. C., Mesquita, J., Matos, M. J., Madureira, A. J., Martínez, E., Sarmento, A., & Medina, J. L. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-180 · Cited by 21 · see citing works

Hypertension in treated and untreated patients with HIV: a study from 2011 to 2013 at the Jos University Teaching Hospital, Nigeria

Isa, S. E., Kang'ombe, A. R., Simji, G. S., Shehu, N. Y., Oche, A. O., Idoko, J. A., Cuevas, L. E., & Gill, G. V. (2017) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trx030 · Cited by 21 · see citing works

A pilot study to examine the acceptability and health effects of electronic cigarettes in HIV-positive smokers

Cioe, P. A., Mercurio, A. N., Lechner, W. V., Costantino, C., Tidey, J. W., Eissenberg, T., & Kahler, C. W. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107678 · Cited by 20 · see citing works

Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV disease

Longo‐Mbenza, B., Ndona, M., Wumba, R., Tandu‐Umba, B., Buassa-bu-Tsumbu, Situakibanza, H., Mambimbi, M., Dalida, K. N., & Mbungu (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s32167 · Cited by 19 · see citing works

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients

Badiou, S., Thiébaut, R., Aurillac-Lavignolle, V., Dabis, F., Laporte, F., Cristol, J., & Mercié, P. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.05.007 · Cited by 19 · see citing works

Clinical Inertia in the Management of Low‐Density Lipoprotein Abnormalities in an HIV Clinic

Willig, J. H., Jackson, D. A., Westfall, A. O., Allison, J. J., Chang, P., Raper, J. L., Saag, M. S., & Mugavero, M. J. (2008) · Clinical Infectious Diseases · doi:10.1086/533466 · Cited by 18 · see citing works

Prevalence and risk factors of high cholesterol and triglycerides among people with HIV in Texas

Buendia, J. R., Sears, S. C., & Mgbere, O. O. (2022) · AIDS Research and Therapy · doi:10.1186/s12981-022-00467-y · Cited by 17 · see citing works

UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV

Courlet, P., Spaggiari, D., Desfontaine, V., Cavassini, M. L., Saldanha, S. A., Buclin, T., Marzolini, C., Csajka, C., & Decosterd, L. A. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.121733 · Cited by 17 · see citing works

High smoking prevalence among HIV-positive individuals: a systematic review and meta-analysis

Lindayani, L., Yeh, C., Ko, W., & Ko, N. (2019) · Journal of Substance Use · doi:10.1080/14659891.2019.1652364 · Cited by 17 · see citing works

Comparison Between the Framingham and Prospective Cardiovascular of Münster Scores for Risk Assessment of Coronary Heart Disease in Human Immunodeficiency Virus–Positive Patients in Pernambuco, Brazil

Barros, Z. M., de Alencar Ximenes, R. A., Miranda-Filho, D. B., de Albuquerque, M. D. F. P. M., Melo, H. R. L., Carvalho, É. H., Gelenske, T., Diniz, G., & Bandeira, F. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0100 · Cited by 16 · see citing works

Ecological Study of HIV Infection and Hypertension in Sub-Saharan Africa: Is There a Double Burden of Disease?

Angkurawaranon, C., Nitsch, D., Larke, N. L., Rehman, A. M., Smeeth, L. L., & Addo, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166375 · Cited by 16 · see citing works

Predicting smoking cessation and its relapse in HIV ‐infected patients: the S wiss HIV C ohort S tudy

Schäfer, J., Young, J., Bernasconi, E., Ledergerber, B., Nicca, D., Calmy, A., Cavassini, M. L., Furrer, H., Battegay, M., Bucher, H. C., et al. (2014) · HIV Medicine · doi:10.1111/hiv.12165 · Cited by 15 · see citing works

Predictors of hypertension in an urban HIV-infected population at the University of Calabar Teaching Hospital, Calabar, Nigeria

Okpa, H. O., Bisong, E. M., Enang, O., Monjok, E. M., & Essien, E. J. (2017) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s126374 · Cited by 15 · see citing works

Conventional cardiovascular risk factors in HIV infection: how conventional are they?

Sabin, C. A., & Worm, S. W. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282f6a613 · Cited by 15 · see citing works

Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy.

Turčinov, D., Stanley, C. M., Canchola, J. A., Rutherford, G. W., Novotny, T. E., & Begovać, J. (2009) · PubMed · Cited by 14 · see citing works

Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy

Study, S. H. C., Bucher, H. C., Rickenbach, M., Young, J., Glass, T. R., Vallet, Y., Bernasconi, E., Cavassini, M. L., Fux, C. A., Schiffer, V., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1475 · Cited by 14 · see citing works

Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals

Hatleberg, C. I., Ryom, L., El-Sadr, W. M., Smith, C. J., Weber, R. K., Reiss, P., Fontas, É., Dabis, F., Law, M. G., Monforte, A. D., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001076 · Cited by 13 · see citing works

High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study

Schäfer, J., Young, J., Calmy, A., Nicca, D., Hasse, B. K., del Re, C. B., Cavassini, M. L., Bernasconi, E., Schmidt‐Trucksäss, A., Bucher, H. C., et al. (2017) · AIDS Care · doi:10.1080/09540121.2016.1274016 · Cited by 13 · see citing works

Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective

Lawal, I. O., Ankrah, A. O., Stoltz, A. C., & Sathekge, M. M. (2019) · European Journal of Hybrid Imaging · doi:10.1186/s41824-019-0053-7 · Cited by 12 · see citing works

Associations of depression and anxiety with cardiovascular risk among people living with HIV/AIDS in Korea

Park, K. S., Hwang, S. Y., Choi, B. Y., Kim, J. M., Kim, S. I., Kim, W. J., & Kang, C. (2020) · Epidemiology and Health · doi:10.4178/epih.e2021002 · Cited by 11 · see citing works

An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database)

Danjuma, M. I.-M., Mohamad-Fadzillah, N. H., & Khoo, S. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413504747 · Cited by 11 · see citing works

Trends in non-AIDS-related causes of death among adults with HIV/AIDS, Brazil, 1999 to 2010

Fazito, E., Vasconcelos, A. M. N., Pereira, M. G., & de Rezende, D. F. (2013) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00128912 · Cited by 11 · see citing works

Population-Based Study of Risk Factors for Coronary Heart Disease Among HIV-Infected Persons

Oh, J. Y., Greene, K., He, H., Schafer, S., & Hedberg, K. (2012) · The Open AIDS Journal · doi:10.2174/1874613601206010177 · Cited by 11 · see citing works

Patologia cardiovascular associada ao vírus da imunodeficiência humana

Costa, L. A., & Almeida, A. G. (2015) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2015.03.005 · Cited by 10 · see citing works

Ecological Study of the Predictors of Successful Management of Dyslipidemia in HIV-Infected Patients on ART: the Swiss HIV Cohort Study

Glass, T. R., Weber, R. K., Vernazza, P., Rickenbach, M., Furrer, H., Bernasconi, E., Cavassini, M. L., Hirschel, B. J., Battegay, M., Bucher, H. C., et al. (2007) · HIV Clinical Trials · doi:10.1310/hct0802-77 · Cited by 10 · see citing works

Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy

Magenta, L., Dell‐Kuster, S., Richter, W. O., Young, J., Hasse, B. K., Flepp, M., Hirschel, B. J., Vernazza, P., Evison, J., Cavassini, M. L., et al. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0207 · Cited by 9 · see citing works

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study

Wolbers, M., Opravil, M., von Wyl, V., Hirschel, B. J., Furrer, H., Cavassini, M. L., Vernazza, P., Bernasconi, E., Battegay, M., Yerly, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282efacb1 · Cited by 9 · see citing works

Cardiovascular diseases associated with HIV infection and their management

Rawdanowicz, J., Pikto−Pietkiewicz, W., & Marczyńska, M. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0301 · Cited by 9 · see citing works

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar

Aza, E. B., Shetty, S., Ousley, J., Kyaw, N. T. T., Soe, T. T., Soe, K. P., Mon, P. E., Tun, K. T., Ciglenečki, I., Cristofani, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191695 · Cited by 8 · see citing works

4CPS-105 Cardiovascular risk factors in patients with HIV infection with antiretroviral treatment

González, A. F., Carreño, C. A., Ande, A. G., SANGIL, A. F., CAMPORRO, S. F., & Yañez, J. F. (2022) · doi:10.1136/ejhpharm-2022-eahp.393

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

Reinsch, N., Neuhaus, K., Eßer, S., Potthoff, A. V., Hower, M., Mostardt, S., Neumann, A., Brockmeyer, N. H., Gelbrich, G., Erbel, R., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711398431 · Cited by 85 · see citing works

Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy

Estrada, V., Domingo, P., Suárez-Lozano, I., Gutiérrez, F., Knobel, H., Palacios, R., Antela, A., Blanco, J. R., & Refoyo, E. (2019) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.05.012 · Cited by 2 · see citing works

Cardiovascular disease risk factors and antiretroviral therapy in an HIV‐positive UK population

Smith, C. J., Levy, I., Sabin, C. A., Kaya, E. B., Johnson, M., & Lipman, M. C. I. (2004) · HIV Medicine · doi:10.1111/j.1468-1293.2004.00191.x · Cited by 51 · see citing works

Predicted coronary heart disease risk in croatian HIV infected patients treated with combination antiretroviral therapy.

Turčinov, D., & Begovać, J. (2011) · PubMed · Cited by 2 · see citing works